Erasca, Inc. (ERAS) Stock Grade

About Erasca, Inc.'s fundamentals

Erasca is a biotechnology company with a market capitalization of $1.1 billion that reported zero year-over-year revenue growth and a net loss in its latest annual statement, resulting in a 0% net margin. The company does not pay dividends. Standard valuation metrics like P/E ratio and return on equity are not applicable given the company's unprofitable status, which is not uncommon for early-stage biotech firms focused on drug development rather than near-term profitability.